The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Neutralization Of Inhibitory Pathways In Lymphocytes - EP3405495

The patent EP3405495 was granted to Innate Pharma on Feb 24, 2021. The application was originally filed on Jan 20, 2017 under application number EP17702315A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3405495

INNATE PHARMA
Application Number
EP17702315A
Filing Date
Jan 20, 2017
Status
Granted And Under Opposition
Jan 22, 2021
Publication Date
Feb 24, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HOIBERG PSNov 24, 2021ZWICKERADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2013034559
DESCRIPTIONUS5229275
DESCRIPTIONUS5567610
DESCRIPTIONUS8206709
DESCRIPTIONWO03101485
DESCRIPTIONWO2006121168
DESCRIPTIONWO2007005874
DESCRIPTIONWO2008156712
DESCRIPTIONWO2009014708
DESCRIPTIONWO2009101611
DESCRIPTIONWO2009114335
DESCRIPTIONWO2010077634
DESCRIPTIONWO2011066389
DESCRIPTIONWO2012145493
DESCRIPTIONWO2013019906
DESCRIPTIONWO2015085847
DESCRIPTIONWO9928748
INTERNATIONAL-SEARCH-REPORTWO2008009545
INTERNATIONAL-SEARCH-REPORTWO2016041945
OPPOSITIONWO2008009545

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents